NEW YORK--(BUSINESS WIRE)--Callisto Pharmaceuticals, Inc. (Amex: KAL; FWB: CA4), a developer of new drug treatments in the fight against cancer and gastrointestinal disorders, announced today that Gary S. Jacob, Ph.D., Chief Executive Officer of Callisto will present at the BIO CEO & Investor Conference on February 11-13, 2008 at the Waldorf Astoria, New York, NY. Dr. Jacob will provide a company overview and update of Callisto activities. The presentation is scheduled for 2:00 PM ET on Tuesday, February 12th in the West Foyer.
